ISG15 and neoplasm: Patients who showed abundant ISG15 expression in the tumour had an estimated mean RFS of 112 months (95% confidence interval [CI]: 99 to 125) compared with 78 months (95% CI: 68 to 87) in patients with negative/weak ISG15 expression.